IMMUNOSTATUS OF UNTREATED CERVICAL-CARCINOMA

被引：11

作者：

ALSABTI, EAK ^{[1
]}

机构：

[1] ALBAATH SPECIF PROT UNIT,BAGHDAD,IRAQ

来源：

关键词：

D O I：

10.1016/0090-8258(80)90002-5

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：6 / 11

页数：6

共 30 条

[1] ALLISON AC, 1977, CANCER IMMUNOL IMMUN, V2, P151
[2] ALSABTI EAK, ONCOLOGY
[3] BOLTON PM, 1976, CANCER IMMUNOL IMMUN, V1, P251
[4] BURNET FM, 1967, LANCET, V1, P1171
[5] PROGNOSTIC CORRELATIONS IN MALIGNANT-MELANOMA
CLAUDY, AL
VIAC, J
PELLETIER, N
FOUADWASSEF, N
ALARIO, A
THIVOLET, J
[J]. EUROPEAN JOURNAL OF CANCER, 1975, 11 (11) : 821 - 827
[6] SERUM LYSOZYME AS A MARKER OF HOST RESISTANCE .1. PRODUCTION BY MACROPHAGES RESIDENT IN RAT SARCOMATA
CURRIE, GA
ECCLES, SA
[J]. BRITISH JOURNAL OF CANCER, 1976, 33 (01) : 51 - 59
[7] SERUM LYSOZYME AS A MARKER OF HOST-RESISTANCE .2. PATIENTS WITH MALIGNANT-MELANOMA, HYPERNEPHROMA OR BREAST CARCINOMA
CURRIE, GA
[J]. BRITISH JOURNAL OF CANCER, 1976, 33 (06) : 593 - 599
[8] EDWARDS AJ, 1977, CLIN ONCOL, V3, P65
[9] Eilber F R, 1970, Cancer, V25, P362, DOI 10.1002/1097-0142(197002)25:2<362::AID-CNCR2820250213>3.0.CO
[10] 2-V